← Eichor
Study identifier: NCT04474106 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

NEUROwave - Extracorporeal Shock Wave Therapy (ESWT) in Acute Traumatic Complete (AIS A) and Incomplete (AIS B-D) Cross-sectional Lesions on Motor and Sensory Function Within Six Months After Injury

Condition: Acute Traumatic Spinal Cord Injury  ·  Sponsor: AUVA

PhaseNA
Planned participants246
Who can joinAll sexes, 18 Years to 99 Years
Healthy volunteersNo

About this study

It has been hypothesized that there are two mechanisms of acute traumatic spinal cord injury (SCI): the primary mechanical damage and the secondary injury due to additional pathological processes initiated by the primary injury. Neurological damage due to laceration, contusion, distraction or compression of the spinal cord is called ''primary injury''. This mechanical injury leads to a cascade of biochemical and pathological changes, described as ''secondary injury'', which occurs minutes to weeks after the initial trauma and causes further neurological deterioration. This secondary cascade involves vascular changes, an inflammatory response, neurotoxicity, apoptosis and glial scarring, and further compromises neurological impairment after traumatic spinal cord injury. Edema, ischemia and loss of autoregulation continue to spread bi-directionally from the initial lesion along the spinal cord for up to 72 hours after the trauma. It has been postulated that the damage caused by the primary injury mechanism is irreversible and therapeutic approaches in recent years have focused on modulating the secondary injury cascade. Researchers found significantly greater numbers of myelinated fibers in peripheral nerves after a single ESWT application in an experimental model on rats after a homotopic nerve autograft into the sciatic nerve. In another study a spinal cord ischemia model in mice was performed. ESWT was applied immediately after surgery and the treated animals showed a sig…

This description comes directly from the study's public registry record.

Talk to the study team

Wolfgang Schaden, Dr  ·  0043 5 9393 20170  ·  wolfgang.schaden@auva.at

Iris Leister, MSc  ·  iris.leister@pmu.ac.at

Always discuss trial participation with your own doctor first.

Locations (15)

Medical University InnsbruckInnsbruck, Tyrol, AustriaRecruiting
Rehazentrum Bad HäringBad Häring, AustriaActive Not Recruiting
Landeskarnkenhaus FeldkirchFeldkirch, AustriaRecruiting
Unfallkrankenhaus GrazGraz, AustriaRecruiting
Rehazentrum TobelbadGraz, AustriaActive Not Recruiting
Unfallkrankenhaus KlagenfurtKlagenfurt, AustriaRecruiting
Rehazentrum Weißer HofKlosterneuburg, AustriaActive Not Recruiting
Unfallkrankenhaus LinzLinz, AustriaRecruiting
Unfallkrankenhaus SalzburgSalzburg, AustriaRecruiting
Universitätsklinik für Orthopädie und TraumatologieSalzburg, AustriaWithdrawn
Unfallkrankenhaus St. PöltenSankt Pölten, AustriaWithdrawn
Universitätsklinik Wien, AKHVienna, AustriaRecruiting

+ 3 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04474106